• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金缕梅素交联的Ⅰ型胶原与壳聚糖纳米纤维多孔支架及其成骨细胞相容性

The root-like chitosan nanofiber porous scaffold cross-linked by genipin with type I collagen and its osteoblast compatibility.

机构信息

State Key Lab of Pulp and Papermaking Engineering, School of Light Industry and Engineering, South China University of Technology, Guangzhou 510641, China.

State Key Lab of Pulp and Papermaking Engineering, School of Light Industry and Engineering, South China University of Technology, Guangzhou 510641, China.

出版信息

Carbohydr Polym. 2022 Jun 1;285:119255. doi: 10.1016/j.carbpol.2022.119255. Epub 2022 Feb 17.

DOI:10.1016/j.carbpol.2022.119255
PMID:35287869
Abstract

Bone tissue repair is difficult due to the dense structure of the extracellular matrix. To solve this problem, a porous chitosan nanofiber scaffold (CSNFS) with an extracellular matrix-like structure was prepared via a facile cross-linked reaction of root-like chitosan nanofiber (CSNF) and collagen (Col) by using genipin (Gen) as the cross-linker. The optimal preparation conditions of CSNFS is weight ratio of CSNF:Col:Gen =1:1:0.1, crosslinked 48 h under 37 °C. CSNFS shows high porosity with adequate micro-scale pores, and its BET data shows that there are a large number of nano-scale pores. The CSNFS mechanical strength is higher than that of the chitosan scaffold both in dry and wet state. MC3T3 cells grow well on CSNFS, can overgrow the scaffold in three-dimensional space, adhere and differentiate well within those nanofiber structure. The cross-linked CSNFS has good biocompatibility and can be used as a repair material for bone tissue engineering.

摘要

由于细胞外基质的致密结构,骨组织的修复较为困难。为了解决这个问题,通过使用京尼平(Gen)作为交联剂,通过根状壳聚糖纳米纤维(CSNF)和胶原(Col)的简单交联反应,制备了具有细胞外基质样结构的多孔壳聚糖纳米纤维支架(CSNFS)。CSNFS 的最佳制备条件为 CSNF:Col:Gen 的重量比=1:1:0.1,在 37°C 下交联 48 h。CSNFS 具有较高的孔隙率和充足的微尺度孔,其 BET 数据表明存在大量纳米尺度的孔。CSNFS 的机械强度在干燥和湿润状态下均高于壳聚糖支架。MC3T3 细胞在 CSNFS 上生长良好,可在三维空间中覆盖支架,在纳米纤维结构内良好地黏附和分化。交联的 CSNFS 具有良好的生物相容性,可用作骨组织工程的修复材料。

相似文献

1
The root-like chitosan nanofiber porous scaffold cross-linked by genipin with type I collagen and its osteoblast compatibility.金缕梅素交联的Ⅰ型胶原与壳聚糖纳米纤维多孔支架及其成骨细胞相容性
Carbohydr Polym. 2022 Jun 1;285:119255. doi: 10.1016/j.carbpol.2022.119255. Epub 2022 Feb 17.
2
Fabrication and in vivo osteogenesis of biomimetic poly(propylene carbonate) scaffold with nanofibrous chitosan network in macropores for bone tissue engineering.具有大孔中纳米纤维壳聚糖网络的仿生聚碳酸亚丙酯支架的制备及其体内成骨用于骨组织工程。
J Mater Sci Mater Med. 2012 Feb;23(2):517-25. doi: 10.1007/s10856-011-4468-3. Epub 2011 Nov 1.
3
Genipin-crosslinked silk fibroin/hydroxybutyl chitosan nanofibrous scaffolds for tissue-engineering application.基因素交联丝素/羟丁基壳聚糖纳米纤维支架在组织工程中的应用。
J Biomed Mater Res A. 2010 Dec 1;95(3):870-81. doi: 10.1002/jbm.a.32895.
4
Genipin-cross-linked collagen/chitosan biomimetic scaffolds for articular cartilage tissue engineering applications.用于关节软骨组织工程应用的京尼平交联胶原/壳聚糖仿生支架。
J Biomed Mater Res A. 2010 Nov;95(2):465-75. doi: 10.1002/jbm.a.32869.
5
Decellularized nerve extracellular matrix/chitosan crosslinked by genipin to prepare a moldable nerve repair material.原代神经细胞外基质/壳聚糖通过京尼平交联制备可模塑神经修复材料。
Cell Tissue Bank. 2021 Sep;22(3):419-430. doi: 10.1007/s10561-020-09889-2. Epub 2021 Jun 11.
6
Organic Solvent-Free Preparation of Chitosan Nanofibers with High Specific Surface Charge and Their Application in Biomaterials.无有机溶剂制备具有高比表面电荷的壳聚糖纳米纤维及其在生物材料中的应用。
ACS Appl Mater Interfaces. 2021 Mar 17;13(10):12347-12358. doi: 10.1021/acsami.0c21796. Epub 2021 Feb 24.
7
Development of genipin-crosslinked and fucoidan-adsorbed nano-hydroxyapatite/hydroxypropyl chitosan composite scaffolds for bone tissue engineering.用于骨组织工程的京尼平交联和褐藻酸钠吸附纳米羟基磷灰石/羟丙基壳聚糖复合支架的研制。
Int J Biol Macromol. 2019 May 1;128:973-984. doi: 10.1016/j.ijbiomac.2019.02.010. Epub 2019 Feb 8.
8
Polycaprolactone nanofiber interspersed collagen type-I scaffold for bone regeneration: a unique injectable osteogenic scaffold.聚己内酯纳米纤维交织型 I 型胶原蛋白支架用于骨再生:一种独特的可注射成骨支架。
Biomed Mater. 2013 Aug;8(4):045011. doi: 10.1088/1748-6041/8/4/045011. Epub 2013 Jun 27.
9
Mechanical enhancement and in vitro biocompatibility of nanofibrous collagen-chitosan scaffolds for tissue engineering.用于组织工程的纳米纤维胶原-壳聚糖支架的机械增强和体外生物相容性。
J Biomater Sci Polym Ed. 2017 Dec;28(18):2255-2270. doi: 10.1080/09205063.2017.1392672. Epub 2017 Oct 19.
10
[Preparation and characterization of an extracellular matrix of artificial tendon tissue from natural macromolecules].[天然大分子人工肌腱组织细胞外基质的制备与表征]
Sheng Wu Gong Cheng Xue Bao. 2008 Nov;24(11):1907-11.

引用本文的文献

1
Injectable citrate-based polyurethane-urea as a tug-of-war-inspired bioactive self-expansive and planar-fixing screw augmented bone-tendon healing.可注射柠檬酸盐基聚氨酯-脲作为一种受拔河启发的生物活性自膨胀和平面固定螺钉,可增强骨-肌腱愈合。
Bioact Mater. 2024 Jul 16;41:108-126. doi: 10.1016/j.bioactmat.2024.07.004. eCollection 2024 Nov.
2
Towards Polycaprolactone-Based Scaffolds for Alveolar Bone Tissue Engineering: A Biomimetic Approach in a 3D Printing Technique.用于肺泡骨组织工程的聚己内酯基支架:3D 打印技术中的仿生方法。
Int J Mol Sci. 2023 Nov 10;24(22):16180. doi: 10.3390/ijms242216180.
3
The Diamond Concept Enigma: Recent Trends of Its Implementation in Cross-linked Chitosan-Based Scaffolds for Bone Tissue Engineering.
《金刚石概念之谜:其在用于骨组织工程的交联壳聚糖支架中的最新应用趋势》。
ACS Appl Bio Mater. 2023 Jul 17;6(7):2515-2545. doi: 10.1021/acsabm.3c00108. Epub 2023 Jun 13.
4
Chitosan-Based Scaffolds for Facilitated Endogenous Bone Re-Generation.用于促进内源性骨再生的壳聚糖基支架
Pharmaceuticals (Basel). 2022 Aug 19;15(8):1023. doi: 10.3390/ph15081023.
5
A Comparative Study on Two Types of Porcine Acellular Dermal Matrix Sponges Prepared by Thermal Crosslinking and Thermal-Glutaraldehyde Crosslinking Matrix Microparticles.热交联和热-戊二醛交联基质微粒制备的两种猪脱细胞真皮基质海绵的比较研究
Front Bioeng Biotechnol. 2022 Aug 5;10:938798. doi: 10.3389/fbioe.2022.938798. eCollection 2022.